Conventional and High Dose Chemotherapy for Lymphomas
Author:
van Besien Koen W.
Reference94 articles.
1. Frei E, III, Canellos GP: Dose: a critical factor in cancer chemotherapy. Am J Med 69:585, 1980
2. Coiffier B, Philip T, Burnett AK, Symann ML: Consensus conference on intensive chemotherapy plus hematopoietic stem cell transplantation in malignancies, Lyon, June 4–6, 1993. Ann Oncol 5:19, 1994
3. Gottlieb JA, Gutterman JU, McCredie KB, et al. Chemotherapy of malignant lymphoma with adriamycin. Cancer Res 33:3024, 1973
4. McKelvey EM, Gottlieb JA, Wilson HE, et al. Hydroxyldaunomycin (adriamycin) combination chemotherapy in malignant lymphoma. Cancer 38:1484, 1976
5. Fisher RI, Gaynor ER, Dahlberg S, et al. Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin’s lymphoma. N Engl J Med 328:1002, 1993